KATP channel opener NT-KO-003 mediates neuroprotection by a novel mechanism of action and induces beneficial effects in a murine model of multiple sclerosis

被引:0
|
作者
Virgili, N.
Mancera, P.
Pasten-Zamorano, A.
Wappenhans, B.
Sorrosal, G.
De Frias, M.
Campas, C.
Bustos, J.
Pugliese, M.
Espinosa-Parrilla, J. F.
机构
[1] Neurotec Pharma SL, Barcelona, Spain
[2] Advancell SA, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:442 / 442
页数:1
相关论文
共 3 条
  • [1] Neuroprotection and myelin preservation induced by NT-KO-003, a novel candidate for multiple sclerosis treatment
    Virgili, N.
    Mancera, P.
    Wappenhans, B.
    Sorrosal, G.
    De Frias, M.
    Campas, C.
    Bustos, J.
    Pugliese, M.
    Espinosa-Parrilla, J. F.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 238 - 238
  • [2] Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis
    Virgili, Noemi
    Espinosa-Parrilla, Juan F.
    Mancera, Pilar
    Pasten-Zamorano, Andrea
    Gimeno-Bayon, Javier
    Rodriguez, Manuel J.
    Mahy, Nicole
    Pugliese, Marco
    JOURNAL OF NEUROINFLAMMATION, 2011, 8
  • [3] Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis
    Noemí Virgili
    Juan F Espinosa-Parrilla
    Pilar Mancera
    Andrea Pastén-Zamorano
    Javier Gimeno-Bayon
    Manuel J Rodríguez
    Nicole Mahy
    Marco Pugliese
    Journal of Neuroinflammation, 8